Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dysbiosis clinical trials
Every US clinical trial registered for Dysbiosis — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
14 US clinical trials · 8 currently recruiting
The research picture
Dysbiosis has 14 registered US clinical trials, 8 of them open to new participants right now — about 57% of the total.
- 8
- recruiting participants now
- 57%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 3
- top sponsor: Florida State University
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Vanderbilt University Medical Center
NCT05288790
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
Shirish S Barve
NCT06005298
Effect of Peanut Butter on Gut and Metabolic Health
Florida State University
NCT06916936
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
Florida State University
NCT06914375
Personalized GI Motility Responses to Diet
University of Illinois at Urbana-Champaign
NCT06386471
A Study of Healthy Microbiome, Healthy Mind
Mayo Clinic
NCT06020703
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
University of California, Davis
NCT06544954
Effect of Watermelon on Gut and Cardiometabolic Health
Florida State University
NCT06588218
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
Persephone Biosciences
NCT05472688
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
University of Pennsylvania
NCT05622721
Almonds to Improve Gut Health and Decrease Inflammation
Oregon State University
NCT05790564
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
Ohio State University
NCT05318183
Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome
Ohio State University
NCT03973996
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
Emory University
NCT03043300
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Dysbiosis Trial Landscape
ClinicalTrials.gov lists 14 US studies indexed under Dysbiosis, and 8 of those are currently open to recruitment — roughly 57% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Dysbiosis shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Dysbiosis is led by Florida State University with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Dysbiosis?
PlainTrial tracks 14 US clinical trials for Dysbiosis, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Dysbiosis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.